Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity
Immunity · 2024-12 · 57 (12) · 2755-2771.e8
DOI: 10.1016/j.immuni.2024.11.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2024-12. Verfasst von Xinyi Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Multi-cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Unive…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunological Synapses, Immunotherapy, Adoptive. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: ShanghaiTech University, Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Major challenges of chimeric antigen receptor (CAR)-T cell therapy include poor antigen sensitivity and cell persistence. Here, we report a solution to these issues by exploiting CAR phase separation. We found that incorporation of an engineered T cell receptor CD3ε motif, EB6I, into the conventional 28Z or BBZ CAR induced self-phase separation through cation-π interactions. EB6I CAR formed a mature immunological synapse with the CD2 corolla to transduce efficient antigen and costimulatory signaling, although its tonic signaling remained low. Functionally, EB6I CAR-T cells exhibited improved signaling and cytotoxicity against low-antigen tumor cells and persistent tumor-killing function. In multiple primary and relapsed murine tumor models, EB6I CAR-T cells exerted better antitumor functions than conventional CAR-T cells against blood and solid cancers. This study thus unveils a CAR engineering strategy to improve CAR-T cell immunity by leveraging molecular condensation and signaling integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Multi-cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Sha…
- School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
- Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
- Cancer Center, The First Hospital of Jilin University, Changchun, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: wanghp@shanghaitech.edu.cn.
Förderung
- ShanghaiTech University
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences Shanghai Branch
- Chinese Academy of Sciences
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Xu, X., Chen, H., Ren, Z., Xu, X., Wu, W., Yang, H., Wang, J., Zhang, Y., Zhou, Q., Li, H., Zhang, S., Wang, H., & Xu, C. (2024). Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity. Immunity, 57(12), 2755-2771.e8. https://doi.org/10.1016/j.immuni.2024.11.005
Vancouver
Xu X, Chen H, Ren Z, Xu X, Wu W, Yang H, et al. Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity. Immunity. 2024;57(12):2755-2771.e8. doi:10.1016/j.immuni.2024.11.005
BibTeX
@article{Xu2024,
author = {Xu, Xinyi and Chen, Haotian and Ren, Zhengxu and Xu, Xiaomin and Wu, Wei and Yang, Haochen and Wang, JinJiao and Zhang, Yumeng and Zhou, Qiuping and Li, Hua and Zhang, Shaoqing and Wang, Haopeng and Xu, Chenqi},
title = {Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity},
journal = {Immunity},
year = {2024},
volume = {57},
number = {12},
pages = {2755--2771.e8},
doi = {10.1016/j.immuni.2024.11.005}
}
EUVIMED